Y Intercept (Hong Kong) LTD Inovio Pharmaceuticals, Inc. Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $247,109 - $595,596	633,613 New	633,613 $285,000
Q4 2022 Feb 14, 2023	SELL	$1.41 - $2.5 $57,047 - $101,147	-40,459 Closed	0 $0
Q3 2022 Feb 14, 2023	BUY	$1.66 - $2.79 $67,161 - $112,880	40,459 New	40,459 $69,000
Q3 2021 Nov 15, 2021	SELL	$7.16 - $9.69 $119,228 - $161,357	-16,652 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$6.23 - $10.03 $103,741 - $167,019	16,652 New	16,652 $154,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.